• No results found

Experimental therapeutic strategies in restenosis and critical limb ischemia Tongeren, B. van

N/A
N/A
Protected

Academic year: 2021

Share "Experimental therapeutic strategies in restenosis and critical limb ischemia Tongeren, B. van"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Experimental therapeutic strategies in restenosis and critical limb ischemia

Tongeren, B. van

Citation

Tongeren, B. van. (2010, April 22). Experimental therapeutic strategies in restenosis and critical limb ischemia. Retrieved from https://hdl.handle.net/1887/15290

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded

from: https://hdl.handle.net/1887/15290

Note: To cite this publication please use the final published version (if applicable).

(2)

Experimental Therapeutic Strategies in Restenosis and Critical Limb Ischemia

R.B.M. van Tongeren

R.B.M. van Tongeren Experimental Therapeutic Strategies in Restenosis and Critical Limb Ischemia

Referenties

GERELATEERDE DOCUMENTEN

Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by

aim: To assess the diagnostic accuracy of the Doppler derived maximal systolic acceleration (ACC max ) as a novel technique for evaluating peripheral arterial occlusive

Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. Aicher A, Heeschen

Wij hebben een studie verricht naar de toepasbaarheid, de veiligheid en effectiviteit van beenmerg cellen bij patiënten met ernstig perifeer vaatlijden, beschreven in hoofdstuk 6..

In 1998, he began his surgical training in the same Leyenburg Hospital (dr. C.M.A Bruijninckx) and continued this training in the Leiden University Medical Center (prof. In 2004

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on

This shape also occurs in the combination artefacts (see below). The shape is the result of intensive use in a repetitive abrasive motion, carried out from different angles. In